POP-OUT | CLOSE

An Information Portal to 105097 Biological Macromolecular Structures

 
GENISTEIN
 
GEN is found in 7 entries
GEN
  •   Chemical Component Summary   Hide
    Name GENISTEIN
    Identifiers 5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one
    5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one
    Synonyms 5,7-DIHYDROXY-3-(4-HYDROXYPHENYL)-4H-1-BENZOPYRAN-4
    -ONE
    4',5,7-TRIHYDROXYISOFLAVONE
    PRUNETOL
    GENISTEOL
    Formula C15 H10 O5
    Molecular Weight 270.24 g/mol
    Type non-polymer
    Isomeric SMILES
    InChI
    InChI key TZBJGXHYKVUXJN-UHFFFAOYSA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB01645   (Stereoisomeric match)
    Name Genistein
    Groups investigational
    Description An isoflavonoid derived from soy products. It inhibits protein-tyrosine kinase and topoisomerase-II (DNA topoisomerases, type II) activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 phase arrest in human and murine cell lines. Additionally, genistein has antihelmintic activity. It has been determined to be the active ingredient in <I>Felmingia vestita</I>, which is a plant traditionally used against worms. It has also been demonstrated to be effective against intestinal parasites such as the common liver fluke, pork trematode and poultry cestode. [Wikipedia] Further, genistein is a phytoestrogen which has selective estrogen receptor modulator properties. It has been investigated in clinical trials as an alternative to classical hormone therapy to help prevent cardiovascular disease in postmenopausal women. [1] Genistein can be found in food sources such as tofu, fava beans, soybeans, kudzu, and lupin. It is also present in certain cell cultures and medicinal plants. [Wikipedia]
    Synonyms
    • 4',5, 7-Trihydroxyisoflavone
    • 5,7,4'-Trihydroxyisoflavone
    • Genisteol
    • Genisterin
    Brand names
    • Prunetol
    • Sophoricol
    Affected organism
    • Humans and other mammals
    • Helminthic Microorganisms
    • Parasitic nematodes and other roundworms
    Indication Currently Genistein is being studied in clinical trials as a treatment for prostate cancer.
    Mechanism of action Genistein may inhibit cancer cell growth by blocking enzymes required for cell growth. Genistein may decrease cardiovascular risk in postmenopausal women by interacting with the nuclear estrogen receptors to alter the transcription of cell specific genes. In randomized clinical trials, genistein was seen to increase the ratio of nitric oxide to endothelin and improved flow-mediated endothelium dependent vasodilation in healthy postmenopausal women. [1] In addition, genistein may have beneficial effects on glucose metabolism by inhibiting islet tyrosine kinase activity as well as insulin release dependent on glucose and sulfonylurea. [1]
    Categories
    • Protein Kinase Inhibitors
    • Anticarcinogenic Agents
    • Phytoestrogens
    CAS number 446-72-0
    Targets
    Name Sequence search Pharmacological action Actions
    Estrogen receptor   Search  unknown
    DNA topoisomerase 2-alpha   Search  unknown
    DNA topoisomerase 2-alpha   Search  unknown
    Estrogen receptor beta   Search  unknown
    Protein-tyrosine kinase 2-beta   Search  unknown
    [more]
     
Ligand Image